Review



human bone morphogenetic protein 2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems human bone morphogenetic protein 2
    Human Bone Morphogenetic Protein 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pmc12954436-109-9-15?v=R%26D+Systems
    Average 94 stars, based on 22 article reviews
    human bone morphogenetic protein 2 - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    99
    Thermo Fisher gene exp bmp2 hs00154192 m1
    Gene Exp Bmp2 Hs00154192 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pmc13195570-30-7--1?v=Thermo+Fisher
    Average 99 stars, based on 1 article reviews
    gene exp bmp2 hs00154192 m1 - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    89
    Shanghai Korain Biotech Co Ltd changes in col1
    Changes In Col1, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/10__33808_slash_clinexphealthsci__1741726-73-0-4?v=Shanghai+Korain+Biotech+Co+Ltd
    Average 89 stars, based on 1 article reviews
    changes in col1 - by Bioz Stars, 2026-07
    89/100 stars
      Buy from Supplier

    94
    R&D Systems human bone morphogenetic protein 2
    Human Bone Morphogenetic Protein 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pmc12954436-109-9-15?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    human bone morphogenetic protein 2 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Thermo Fisher antibodies against bone morphogenetic protein 2
    Representative images of immunohistochemical staining and histopathological assessment from study specimens. (a) At Week 4, Group II, increased neovascularization (asterisk) is observed between collagen fibre bundles (arrow) within the tendon tissue (H&E staining, ×100 magnification). (b) At Week 4, Group II, collagen fibres stained blue and vascular structures were clearly distinguishable (Masson's trichrome staining, ×100 magnification). (c) Strong cytoplasmic immunopositivity for BMP‐7 in multinucleated cell formations, Group III, staining observed in cell clusters at the tendon–bone interface at Week 8 (immunoperoxidase staining, ×400 magnification). (d) Positive immunopositivity for CD34 was observed in vascular endothelial cells within the tendon region at Week 4, Group II (immunoperoxidase staining, ×200 magnification). (e) Membranous TGF‐β1 staining in the tendon–muscle junction at Week 4, Group I, showing sparse immunopositivity (immunoperoxidase staining, ×400 magnification). (f) Cytoplasmic immunopositivity for BMP‐2 at the tendon–bone interface at Week 8, Group III (immunoperoxidase staining, ×400 magnification). BMP‐2, bone morphogenetic <t>protein‐2;</t> BMP‐7, bone morphogenetic protein‐7; TGF‐β1, transforming growth factor‐β1.
    Antibodies Against Bone Morphogenetic Protein 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pmc12793047-113-24-42?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    antibodies against bone morphogenetic protein 2 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology elisa kit
    Representative images of immunohistochemical staining and histopathological assessment from study specimens. (a) At Week 4, Group II, increased neovascularization (asterisk) is observed between collagen fibre bundles (arrow) within the tendon tissue (H&E staining, ×100 magnification). (b) At Week 4, Group II, collagen fibres stained blue and vascular structures were clearly distinguishable (Masson's trichrome staining, ×100 magnification). (c) Strong cytoplasmic immunopositivity for BMP‐7 in multinucleated cell formations, Group III, staining observed in cell clusters at the tendon–bone interface at Week 8 (immunoperoxidase staining, ×400 magnification). (d) Positive immunopositivity for CD34 was observed in vascular endothelial cells within the tendon region at Week 4, Group II (immunoperoxidase staining, ×200 magnification). (e) Membranous TGF‐β1 staining in the tendon–muscle junction at Week 4, Group I, showing sparse immunopositivity (immunoperoxidase staining, ×400 magnification). (f) Cytoplasmic immunopositivity for BMP‐2 at the tendon–bone interface at Week 8, Group III (immunoperoxidase staining, ×400 magnification). BMP‐2, bone morphogenetic <t>protein‐2;</t> BMP‐7, bone morphogenetic protein‐7; TGF‐β1, transforming growth factor‐β1.
    Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pm41519798-92-1-4?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    elisa kit - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology bmp 2 protein
    Overview of the experimental workflow. The workflow illustrates key steps, including UC-MSCs isolation, plasmid construction, gene transfection and evaluation, secretome <t>production,</t> <t>BMP-2</t> mRNA and protein quantifications, and secretome-BMP-2 functional assay in osteogenic differentiation of untransfected cells. (Created in BioRender. Fahdia, N. (2026). https://BioRender.com/2bdayt7 ).
    Bmp 2 Protein, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/pmc12838044-92-2-15?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    bmp 2 protein - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology human bmp 2 elisa kit
    Overview of the experimental workflow. The workflow illustrates key steps, including UC-MSCs isolation, plasmid construction, gene transfection and evaluation, secretome <t>production,</t> <t>BMP-2</t> mRNA and protein quantifications, and secretome-BMP-2 functional assay in osteogenic differentiation of untransfected cells. (Created in BioRender. Fahdia, N. (2026). https://BioRender.com/2bdayt7 ).
    Human Bmp 2 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bone+morphogenetic+protein+2/10__3390_slash_biomedicines14010076-101-11-15?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    human bmp 2 elisa kit - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    Representative images of immunohistochemical staining and histopathological assessment from study specimens. (a) At Week 4, Group II, increased neovascularization (asterisk) is observed between collagen fibre bundles (arrow) within the tendon tissue (H&E staining, ×100 magnification). (b) At Week 4, Group II, collagen fibres stained blue and vascular structures were clearly distinguishable (Masson's trichrome staining, ×100 magnification). (c) Strong cytoplasmic immunopositivity for BMP‐7 in multinucleated cell formations, Group III, staining observed in cell clusters at the tendon–bone interface at Week 8 (immunoperoxidase staining, ×400 magnification). (d) Positive immunopositivity for CD34 was observed in vascular endothelial cells within the tendon region at Week 4, Group II (immunoperoxidase staining, ×200 magnification). (e) Membranous TGF‐β1 staining in the tendon–muscle junction at Week 4, Group I, showing sparse immunopositivity (immunoperoxidase staining, ×400 magnification). (f) Cytoplasmic immunopositivity for BMP‐2 at the tendon–bone interface at Week 8, Group III (immunoperoxidase staining, ×400 magnification). BMP‐2, bone morphogenetic protein‐2; BMP‐7, bone morphogenetic protein‐7; TGF‐β1, transforming growth factor‐β1.

    Journal: Journal of Experimental Orthopaedics

    Article Title: Comparative effects of bone marrow stimulation and shockwave therapy on rotator cuff healing in chronic massive rotator cuff tears: A rat model study

    doi: 10.1002/jeo2.70622

    Figure Lengend Snippet: Representative images of immunohistochemical staining and histopathological assessment from study specimens. (a) At Week 4, Group II, increased neovascularization (asterisk) is observed between collagen fibre bundles (arrow) within the tendon tissue (H&E staining, ×100 magnification). (b) At Week 4, Group II, collagen fibres stained blue and vascular structures were clearly distinguishable (Masson's trichrome staining, ×100 magnification). (c) Strong cytoplasmic immunopositivity for BMP‐7 in multinucleated cell formations, Group III, staining observed in cell clusters at the tendon–bone interface at Week 8 (immunoperoxidase staining, ×400 magnification). (d) Positive immunopositivity for CD34 was observed in vascular endothelial cells within the tendon region at Week 4, Group II (immunoperoxidase staining, ×200 magnification). (e) Membranous TGF‐β1 staining in the tendon–muscle junction at Week 4, Group I, showing sparse immunopositivity (immunoperoxidase staining, ×400 magnification). (f) Cytoplasmic immunopositivity for BMP‐2 at the tendon–bone interface at Week 8, Group III (immunoperoxidase staining, ×400 magnification). BMP‐2, bone morphogenetic protein‐2; BMP‐7, bone morphogenetic protein‐7; TGF‐β1, transforming growth factor‐β1.

    Article Snippet: For the purpose of histopathological evaluation, hematoxylin–eosin (H&E) staining and Masson's trichrome staining were performed in accordance with standard protocols, and for immunohistochemical analysis, antibodies against bone morphogenetic protein‐2 (BMP‐2), bone morphogenetic protein‐7 (BMP‐7) and transforming growth factor‐β1 (TGF‐β1) were obtained from Invitrogen (Thermo Fisher Scientific) and CD34 from Dako (Glostrup).

    Techniques: Immunohistochemical staining, Staining, Immunoperoxidase Staining

    Overview of the experimental workflow. The workflow illustrates key steps, including UC-MSCs isolation, plasmid construction, gene transfection and evaluation, secretome production, BMP-2 mRNA and protein quantifications, and secretome-BMP-2 functional assay in osteogenic differentiation of untransfected cells. (Created in BioRender. Fahdia, N. (2026). https://BioRender.com/2bdayt7 ).

    Journal: Biomedicines

    Article Title: Genetic Engineering of Umbilical Cord-Derived Mesenchymal Stem Cells to Enhance BMP-2 Secretion via Signal Peptide Optimization

    doi: 10.3390/biomedicines14010076

    Figure Lengend Snippet: Overview of the experimental workflow. The workflow illustrates key steps, including UC-MSCs isolation, plasmid construction, gene transfection and evaluation, secretome production, BMP-2 mRNA and protein quantifications, and secretome-BMP-2 functional assay in osteogenic differentiation of untransfected cells. (Created in BioRender. Fahdia, N. (2026). https://BioRender.com/2bdayt7 ).

    Article Snippet: Quantification of BMP-2 protein in the secretome was performed using a human BMP-2 ELISA kit (Elabscience, Wuhan, China) according to the manufacturer’s protocol.

    Techniques: Isolation, Plasmid Preparation, Transfection, Functional Assay

    Design of the plasmid incorporating a signal peptide in the BMP-2 sequence. The SP sequence is located at the N-terminus of the BMP-2 amino acid sequence and consists of the N-, H-, and C-regions. The SP sequence is directly fused to the BMP-2 sequence to facilitate efficient targeting into the secretory pathway.

    Journal: Biomedicines

    Article Title: Genetic Engineering of Umbilical Cord-Derived Mesenchymal Stem Cells to Enhance BMP-2 Secretion via Signal Peptide Optimization

    doi: 10.3390/biomedicines14010076

    Figure Lengend Snippet: Design of the plasmid incorporating a signal peptide in the BMP-2 sequence. The SP sequence is located at the N-terminus of the BMP-2 amino acid sequence and consists of the N-, H-, and C-regions. The SP sequence is directly fused to the BMP-2 sequence to facilitate efficient targeting into the secretory pathway.

    Article Snippet: Quantification of BMP-2 protein in the secretome was performed using a human BMP-2 ELISA kit (Elabscience, Wuhan, China) according to the manufacturer’s protocol.

    Techniques: Plasmid Preparation, Sequencing

    Evaluation of transfection efficiency, cell viability, and BMP-2 secretion in UC-MSCs transfected with different signal peptide constructs: ( A ) Representative brightfield and fluorescence microscopy images showing GFP expression. ( B ) Representative flow cytometry dot plots showing GFP-negative (untransfected) and GFP-positive (transfected) UC-MSC populations. ( C ) Quantitative analysis of GFP expression (%). ( D ) Cell viability (%) after transfection. ( E ) Relative BMP2 mRNA expression quantified by qRT-PCR and ( F ) BMP-2 protein secretion quantified by ELISA at 48 h post-transfection. ( G ) BMP-2 protein levels in UC-MSC secretome across serial passages. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test; p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).

    Journal: Biomedicines

    Article Title: Genetic Engineering of Umbilical Cord-Derived Mesenchymal Stem Cells to Enhance BMP-2 Secretion via Signal Peptide Optimization

    doi: 10.3390/biomedicines14010076

    Figure Lengend Snippet: Evaluation of transfection efficiency, cell viability, and BMP-2 secretion in UC-MSCs transfected with different signal peptide constructs: ( A ) Representative brightfield and fluorescence microscopy images showing GFP expression. ( B ) Representative flow cytometry dot plots showing GFP-negative (untransfected) and GFP-positive (transfected) UC-MSC populations. ( C ) Quantitative analysis of GFP expression (%). ( D ) Cell viability (%) after transfection. ( E ) Relative BMP2 mRNA expression quantified by qRT-PCR and ( F ) BMP-2 protein secretion quantified by ELISA at 48 h post-transfection. ( G ) BMP-2 protein levels in UC-MSC secretome across serial passages. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test; p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).

    Article Snippet: Quantification of BMP-2 protein in the secretome was performed using a human BMP-2 ELISA kit (Elabscience, Wuhan, China) according to the manufacturer’s protocol.

    Techniques: Transfection, Construct, Fluorescence, Microscopy, Expressing, Flow Cytometry, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay